Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of Telomir Pharmaceuticals (NASDAQ:TELO) through any online brokerage.
Other companies in Telomir Pharmaceuticals’s space includes: Eli Lilly and Co (NYSE:LLY), Johnson & Johnson (NYSE:JNJ), Merck & Co Inc (NYSE:MRK), Novartis AG (NYSE:NVS) and AstraZeneca PLC (NYSE:AZN).
There is no analysis for Telomir Pharmaceuticals to provide a consensus price target.
The stock price for Telomir Pharmaceuticals (NASDAQ: TELO) is $1.1191 last updated August 14, 2026 at 2:07 PM EDT.
There are no upcoming dividends for Telomir Pharmaceuticals.
Telomir Pharmaceuticals does not have any upcoming earnings scheduled.
There is no upcoming split for Telomir Pharmaceuticals.
Telomir Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.